Odyssey Healthcare — Investor Presentation (November 2007)
28 slides from Odyssey Healthcare's investor presentation, Nov 28, 2007

Slide 1: To Serve All People During the End of Life’s Journey
To Serve All People During the End of Life’s Journey

Slide 2: Forward-Looking Statements
FORWARD-LOOKING STATEMENTS Certain statements contained in this presentation are forward-looking statements within the meaning of the federal securities laws. Such forward-looking statements are based on management’s current expectations and are subject to known and unknown risks, uncertainties and

Slide 3: Odyssey… A Leader in Hospice Care
ODYSSEY… A LEADER IN HOSPICE CARE 76 Medicare Certified Programs in 30 states 33,226 admissions in 2006 CAGR revenue = 25.1%

Slide 4: Why Odyssey?
WHY ODYSSEY? Growing recognition of end of life services Aging population assures increased demand Strong balance sheet/cash surplus Compelling operating/growth strategy

Slide 5: Value Proposition
VALUE PROPOSITION Ideally positioned in growing industry Company is fulfilling documented social need Sufficient funding to support growth plan and operate in current reimbursement environment Experienced management team with strong operating background

Slide 6: Odyssey Locations
ODYSSEY LOCATIONS Hospice Office Inpatient Facility Corporate Office - Dallas

Slide 7: What Is Hospice?
WHAT IS HOSPICE?More cost effective Services provided primarily in home Provides quality of life for terminal patients and families Focus on physical, emotional and spiritual

Slide 8: Covered by Medicare
COVERED BY MEDICARE Benefit enacted in 1983 Aggregate per beneficiary cap of $21,410 Largest payer at 90% is Medicare Six months life expectancy Service promoted by CMS

Slide 9: Market Opportunity
MARKET OPPORTUNITY Sudden Death/ Other hospice Patients Served 41% 2.5 million deaths annually in U.S. 42% Estimated Under-Served Market 17%

Slide 10: Patients by Diagnosis in the Industry
PATIENTS BY DIAGNOSIS IN THE INDUSTRY Heart Disease12.2%20% 8.9% 46% 8.2% Other Dementia Cancer Lung Disease Kidney Disease 3.1% Liver Disease 1.6%

Slide 11: Rapidly Growing Market
RAPIDLY GROWING MARKET Hospice Medicare Expenditures ($ in billions) $2.9 $3.6 $4.5 $5.7 $8.2 FY 2000 FY 2001 FY 2002 FY 2003 FY 2005 $6.9 FY 2004

Slide 12: Hospice Types
HOSPICE TYPES SNF-based 1% Home Health-based 23% 19% 57% Hospital-based Free standing

Slide 13: Strategic Focus
STRATEGIC FOCUS Service excellence Refine growth strategiesAccelerate revenue growth, increase volume and manage costs

Slide 14: Growth Strategy
GROWTH STRATEGY Growth Same store growth De NovosAcquisitions

Slide 15: Same Store Growth
SAME STORE GROWTH Continue to refine marketing strategies Continue offering full spectrum of services to increase market share Leverage footprint by opening alternate delivery sites

Slide 16: Criteria for De Novos
Growing markets Broad base of referral sources Regulatory environment Competitive advantage CRITERIA FOR DE NOVOS

Slide 17: Acquisitions
ACQUISITIONS Strategic acquisitions Cap management Market entry Market consolidation Disciplined pricing strategy Strong cash position and balance sheet

Slide 18: Medicare Cap Management
MEDICARE CAP MANAGEMENT Increase short-term admissions Balance mix of patients Open inpatient units

Slide 19: Inpatient Unit Development
INPATIENT UNIT DEVELOPMENT Two strategies Medicare cap acute, short stay patients Grow market share create differentiation One to two new projects per year Opening losses approximating $700,000

Slide 20: Financial Summary
et HealthCare SSEY FINANCIAL SUMMARY —_ —

Slide 21: Net Revenue Growth from Continuing Operations
2002 2003 2004 2006 2005 Q307 Q306 2001 Title: NET REVENUE GROWTH FROM CONTINUING OPERATIONS CAGR 25.1% $130.2 $194.3 $267.9 $333.3 $399.0 $369.2 $104.3 $100.2 ($ in millions)

Slide 22: Admissions from Continuing Operations
ADMISSIONS FROM CONTINUING OPERATIONS 15,969 21,764 26,330 30,084 33,226 32,347 8,014 7,960 2001 2002 2003 2004 2006 2005 Q307q306

Slide 23: Average Length of Stay from Continuing Operations
AVERAGE LENGTH OF STAY FROM CONTINUING OPERATIONS 74 79 82 86 90 86 2003 2004 2006 2005 Q307 Q306 (Days)

Slide 24: Average Daily Census from Continuing Operations
AVERAGE DAILY CENSUS FROM CONTINUING OPERATIONS 3,044 4,404 5,878 7,206 8,085 7,664 8,074 8,149 2001 2002 2003 2004 2006 2005 Q307 Q306

Slide 25: Income from Continuing Operations
INCOME FROM CONTINUING OPERATIONS (a) Excludes charge for settlement with Department of Justice of $9.6 million, net of tax. A reconciliation of GAAP to non-GAAP financial measures are available on the Investor Relations page of Odyssey’s website at www.odsyhealth.com. $30.1(a) $12.9 $21.4 $30.5 $33

Slide 26: Net Cash from Continuing Operations
NET CASH FROM CONTINUING OPERATIONS Exclusive of $13 million for Department of Justice payment $27.6 $47.1 $45.6 $47.9 $8.3 $3.2 2003 2004 2006 2005 Q307 Q306 ($ in millions)

Slide 27: Value Proposition
VALUE PROPOSITION Ideally positioned in growing industry Company is fulfilling documented social need Sufficient funding to support growth plan and operate in current reimbursement environment Experienced management team with strong operating background

Slide 28: To Serve All People During the End of Life’s Journey
To Serve All People During the End of Life’s Journey
Source: SEC EDGAR · 8-K filed Nov 28, 2007
More decks from Odyssey Healthcare Inc
Investor Presentation (November 2008)36 slides · Nov 4, 2008
Investor Presentation (May 2008)44 slides · May 22, 2008
Q1 2008 Earnings Presentation22 slides · May 15, 2008
Investor Presentation (March 2008)46 slides · Mar 18, 2008
Investor Presentation (February 2008)44 slides · Feb 13, 2008
Investor Presentation (January 2008)43 slides · Jan 10, 2008